NeoGenomics, Inc. (NEO) is a publicly traded Healthcare sector company. As of May 21, 2026, NEO trades at $8.85 with a market cap of $1.09B and a P/E ratio of 0.00. NEO moved +6.08% today. Year to date, NEO is -26.32%; over the trailing twelve months it is +11.39%. Its 52-week range spans $4.72 to $19.12. Analyst consensus is buy with an average price target of $14.94. Rallies surfaces NEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are NEO's key financials?
NEO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NEO recently traded at $8.85. Market cap is $1.09B. P/E ratio is 0.00. Revenue is $727.33M.
NEO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NEO recently traded at $8.85. Market cap is $1.09B. P/E ratio is 0.00. Revenue is $727.33M.
Is NEO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NEO. It does not provide personalized investment advice.
